Skip to main content
. 2021 Apr 7;11(4):226. doi: 10.3390/metabo11040226

Figure 6.

Figure 6

DHEA (G6PD inhibitor) decreased the 13C enrichments of HUVEC glycolytic and TCA metabolites, as well as amino acids, R5P, and nucleotide precursors UMP and AMP. (a) Heatmap comparing 13C metabolite enrichment of untreated HUVECs and DHEA-treated HUVECs. 13C enrichment of (b) glycolytic metabolites, (c) TCA metabolites, (d) amino acids, (e) R5P, and (f) UMP, AMP, and UDP-glucose. Statistical significance for (bf) determined through Welch’s unequal variances t-test; * p < 0.05; ** p < 0.01; *** p < 0.001, **** p < 0.0001. n = 6 biological replicates.